Concord Biotech Faces Significant Market Challenges Amidst Broader Sector Volatility
Concord Biotech has faced notable volatility, opening with a loss and underperforming its sector significantly. The stock has declined consecutively over the past week and month, trading below multiple moving averages. Its performance starkly contrasts with the broader market, highlighting ongoing challenges for the company.
Concord Biotech, a midcap player in the Pharmaceuticals & Drugs industry, has experienced significant volatility today, opening with a loss of 4.37%. The stock has underperformed its sector by 8.4%, reflecting broader challenges in the market. Over the past week, Concord Biotech has faced a consecutive decline, with returns plummeting by 33.41%. Today, the stock reached an intraday low of Rs 1529.45, marking a decrease of 9.67%. This downward trend is further highlighted by its performance metrics, as Concord Biotech is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.
In terms of broader market comparison, Concord Biotech's one-day performance stands at -10.67%, contrasting sharply with the Sensex, which has only dipped by 0.66%. Over the past month, the stock has declined by 30.54%, while the Sensex has seen a modest decrease of 1.54%. These figures underscore the challenges facing Concord Biotech in the current market environment.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
